| Authors: |
Engelhardt EG; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Binuya MAE; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., Pharoah PDP; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Poncet C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Rutgers EJT; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Piccart M; Oncology Department, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., van 't Veer LJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Steyerberg EW; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: mk.schmidt@nki.nl. |
